Loading...
XHKG1358
Market cap199mUSD
Dec 23, Last price  
1.01HKD
1D
2.02%
1Q
-9.82%
Jan 2017
-50.00%
IPO
-70.72%
Name

PW Medtech Group Ltd

Chart & Performance

D1W1MN
XHKG:1358 chart
P/E
9.49
P/S
2.15
EPS
0.10
Div Yield, %
4.63%
Shrs. gr., 5y
-0.04%
Rev. gr., 5y
16.78%
Revenues
675m
+25.75%
331,541,000457,083,000608,059,000515,587,000319,583,000286,913,000310,813,000362,183,000247,352,000271,399,000536,826,000675,084,000
Net income
153m
+44.46%
44,668,00077,905,000176,630,000208,582,000109,136,0004,519,000114,812,00081,982,000631,814,000739,120,000106,041,000153,184,000
CFO
211m
-21.62%
24,906,00052,807,00086,100,000259,975,000266,762,999183,777,00097,705,00099,993,00078,204,00037,243,000269,233,000211,031,000
Dividend
Nov 04, 20240.045 HKD/sh
Earnings
Jun 13, 2025

Profile

PW Medtech Group Limited, an investment holding company, operates as a medical device company in the People's Republic of China. The company manufactures and sells infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light resistant infusion sets, intravenous cannula products, and insulin needles and pens. It also provides property management services. The company was formerly known as Pyholding Limited. PW Medtech Group Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
URL
https://www.pwmedtech.com/
IPO date
Nov 08, 2013
Employees
1,187
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
675,084
25.75%
536,826
97.80%
271,399
9.72%
Cost of revenue
530,423
468,545
248,685
Unusual Expense (Income)
NOPBT
144,661
68,281
22,714
NOPBT Margin
21.43%
12.72%
8.37%
Operating Taxes
26,044
28,880
1,653
Tax Rate
18.00%
42.30%
7.28%
NOPAT
118,617
39,401
21,061
Net income
153,184
44.46%
106,041
-85.65%
739,120
16.98%
Dividends
(71,597)
(2,062,188)
Dividend yield
5.58%
131.41%
Proceeds from repurchase of equity
(3,064)
BB yield
0.31%
Debt
Debt current
759
3,113
2,442
Long-term debt
1,497
5,369
2,442
Deferred revenue
23,114
16,005
Other long-term liabilities
177,432
Net debt
(1,653,580)
(1,469,394)
(2,416,889)
Cash flow
Cash from operating activities
211,031
269,233
37,243
CAPEX
(47,306)
(52,461)
(11,321)
Cash from investing activities
(26,665)
(1,082,328)
2,636,329
Cash from financing activities
17,534
(85,164)
(2,091,211)
FCF
237,374
(484,466)
2,166,677
Balance
Cash
1,594,556
1,387,547
2,411,773
Long term investments
61,280
90,329
10,000
Excess cash
1,622,082
1,451,035
2,408,203
Stockholders' equity
2,942,339
3,147,679
2,299,451
Invested Capital
3,381,463
3,169,327
1,501,751
ROIC
3.62%
1.69%
1.03%
ROCE
2.89%
1.43%
0.60%
EV
Common stock shares outstanding
1,565,632
1,566,123
1,569,276
Price
0.82
30.16%
0.63
-37.00%
1.00
-53.27%
Market cap
1,283,818
30.12%
986,657
-37.13%
1,569,276
-53.27%
EV
410,882
209,595
(847,613)
EBITDA
242,922
146,859
54,126
EV/EBITDA
1.69
1.43
Interest
154
464
605
Interest/NOPBT
0.11%
0.68%
2.66%